Landos Biopharma, Inc.
News
AbbVie Completes Acquisition of Landos Biopharma
PR Newswire AbbVie Completes Acquisition of Landos Biopharma AbbVie Completes Acquisition of Landos Biopharma PR Newswire NORTH CHICAGO, Ill., May 23, 2024 - Adds first-in-class investigational asset, NX-13, to...\n more…
LANDOS BIOPHARMA INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Landos Biopharma, Inc. - LAB
Business Wire Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (KSF) are investigating the proposed sale of Landos Biopharma, Inc. (NasdaqCM: LABP) to...\n more…
LABP Stock Earnings: Landos Biopharma Misses EPS for Q1 2024
InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nLABP stock results show that Landos Biopharma missed analyst estimates for earnings per share the first quarter of 2024.\nThe post LABP...\n more…
Landos Biopharma (NASDAQ:LABP) Shares Down 0.2%
Ticker Report Landos Biopharma, Inc. (NASDAQ:LABP - Get Free Report)'s share price traded down 0.2% during trading on Thursday . The stock traded as low as $21.91 and last traded at $22.25. 6,316 shares traded...\n more…
Stockholder Alert: Ademi LLP continues Investigation of the Fairness of Landos Biopharma, Inc.'s transaction with AbbVie
PR Newswire Stockholder Alert: Ademi LLP continues Investigation of the Fairness of Landos Biopharma, Inc.'s transaction with AbbVie Stockholder Alert: Ademi LLP continues Investigation of the Fairness of Landos...\n more…